These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14570885)

  • 21. A synthetic TLR4 antagonist has anti-inflammatory effects in two murine models of inflammatory bowel disease.
    Fort MM; Mozaffarian A; Stöver AG; Correia Jda S; Johnson DA; Crane RT; Ulevitch RJ; Persing DH; Bielefeldt-Ohmann H; Probst P; Jeffery E; Fling SP; Hershberg RM
    J Immunol; 2005 May; 174(10):6416-23. PubMed ID: 15879143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell activation by monosaccharide lipid A analogues utilizing Toll-like receptor 4.
    Tamai R; Asai Y; Hashimoto M; Fukase K; Kusumoto S; Ishida H; Kiso M; Ogawa T
    Immunology; 2003 Sep; 110(1):66-72. PubMed ID: 12941142
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.
    Iwahashi M; Yamamura M; Aita T; Okamoto A; Ueno A; Ogawa N; Akashi S; Miyake K; Godowski PJ; Makino H
    Arthritis Rheum; 2004 May; 50(5):1457-67. PubMed ID: 15146415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos.
    Agrawal S; Agrawal A; Doughty B; Gerwitz A; Blenis J; Van Dyke T; Pulendran B
    J Immunol; 2003 Nov; 171(10):4984-9. PubMed ID: 14607893
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells.
    Napolitani G; Rinaldi A; Bertoni F; Sallusto F; Lanzavecchia A
    Nat Immunol; 2005 Aug; 6(8):769-76. PubMed ID: 15995707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8.
    Gorden KB; Gorski KS; Gibson SJ; Kedl RM; Kieper WC; Qiu X; Tomai MA; Alkan SS; Vasilakos JP
    J Immunol; 2005 Feb; 174(3):1259-68. PubMed ID: 15661881
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rationally Designed TLR4 Ligands for Vaccine Adjuvant Discovery.
    Gregg KA; Harberts E; Gardner FM; Pelletier MR; Cayatte C; Yu L; McCarthy MP; Marshall JD; Ernst RK
    mBio; 2017 May; 8(3):. PubMed ID: 28487429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhancement of endotoxin activity by muramyldipeptide.
    Takada H; Yokoyama S; Yang S
    J Endotoxin Res; 2002; 8(5):337-42. PubMed ID: 12537692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasmacytoid dendritic cells produce cytokines and mature in response to the TLR7 agonists, imiquimod and resiquimod.
    Gibson SJ; Lindh JM; Riter TR; Gleason RM; Rogers LM; Fuller AE; Oesterich JL; Gorden KB; Qiu X; McKane SW; Noelle RJ; Miller RL; Kedl RM; Fitzgerald-Bocarsly P; Tomai MA; Vasilakos JP
    Cell Immunol; 2002; 218(1-2):74-86. PubMed ID: 12470615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of toll-like receptor 2 gene expression in macrophage response to peptidoglycan and high concentration of lipopolysaccharide is involved in NF-kappa b activation.
    Liu Y; Wang Y; Yamakuchi M; Isowaki S; Nagata E; Kanmura Y; Kitajima I; Maruyama I
    Infect Immun; 2001 May; 69(5):2788-96. PubMed ID: 11292690
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunostimulatory activity of aminoalkyl glucosaminide 4-phosphates (AGPs): induction of protective innate immune responses by RC-524 and RC-529.
    Baldridge JR; Cluff CW; Evans JT; Lacy MJ; Stephens JR; Brookshire VG; Wang R; Ward JR; Yorgensen YM; Persing DH; Johnson DA
    J Endotoxin Res; 2002; 8(6):453-8. PubMed ID: 12697089
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like receptors 2 and 4, and acute phase cytokine gene expression in dexamethasone and growth hormone treated dairy calves.
    Eicher SD; McMunn KA; Hammon HM; Donkin SS
    Vet Immunol Immunopathol; 2004 Apr; 98(3-4):115-25. PubMed ID: 15010221
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CD11b/CD18 acts in concert with CD14 and Toll-like receptor (TLR) 4 to elicit full lipopolysaccharide and taxol-inducible gene expression.
    Perera PY; Mayadas TN; Takeuchi O; Akira S; Zaks-Zilberman M; Goyert SM; Vogel SN
    J Immunol; 2001 Jan; 166(1):574-81. PubMed ID: 11123339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different domains of Pseudomonas aeruginosa exoenzyme S activate distinct TLRs.
    Epelman S; Stack D; Bell C; Wong E; Neely GG; Krutzik S; Miyake K; Kubes P; Zbytnuik LD; Ma LL; Xie X; Woods DE; Mody CH
    J Immunol; 2004 Aug; 173(3):2031-40. PubMed ID: 15265938
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages.
    Itoh K; Udagawa N; Kobayashi K; Suda K; Li X; Takami M; Okahashi N; Nishihara T; Takahashi N
    J Immunol; 2003 Apr; 170(7):3688-95. PubMed ID: 12646634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity.
    Link C; Gavioli R; Ebensen T; Canella A; Reinhard E; Guzmán CA
    Eur J Immunol; 2004 Mar; 34(3):899-907. PubMed ID: 14991620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
    Toshchakov V; Jones BW; Perera PY; Thomas K; Cody MJ; Zhang S; Williams BR; Major J; Hamilton TA; Fenton MJ; Vogel SN
    Nat Immunol; 2002 Apr; 3(4):392-8. PubMed ID: 11896392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergistic stimulation of human monocytes and dendritic cells by Toll-like receptor 4 and NOD1- and NOD2-activating agonists.
    Fritz JH; Girardin SE; Fitting C; Werts C; Mengin-Lecreulx D; Caroff M; Cavaillon JM; Philpott DJ; Adib-Conquy M
    Eur J Immunol; 2005 Aug; 35(8):2459-70. PubMed ID: 16021602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages.
    Carl VS; Brown-Steinke K; Nicklin MJ; Smith MF
    J Biol Chem; 2002 May; 277(20):17448-56. PubMed ID: 11877429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of lipopolysaccharide binding protein, CD14, and Toll-like receptors in the initiation of innate immune responses by Treponema glycolipids.
    Schröder NW; Opitz B; Lamping N; Michelsen KS; Zähringer U; Göbel UB; Schumann RR
    J Immunol; 2000 Sep; 165(5):2683-93. PubMed ID: 10946299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.